Cargando…

Prospecting for an HIV vaccine

Human immunodeficiency virus (HIV) sets several challenges for the development of a preventative HIV vaccine. Predictable, protective natural immunity against HIV does not occur and so unlike most other diseases for which vaccines exist, there are few guideposts from natural infection. Nonetheless,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brett-Major, D. M., Crowell, T. A., Michael, N. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530924/ https://www.ncbi.nlm.nih.gov/pubmed/28883976 http://dx.doi.org/10.1186/s40794-017-0050-4

Ejemplares similares

Are you PEPped and PrEPped for travel? Risk mitigation of HIV infection for travelers
por: Brett-Major, D. M., et al.
Publicado: (2016)

New prospects for a preventive HIV-1 vaccine
por: Brown, Jeffrey, et al.
Publicado: (2015)

Fielding vaccines—challenges and opportunities in outbreaks, complex emergencies, and mass gatherings
por: Fischer, Laura J., et al.
Publicado: (2022)

Leveraging early HIV diagnosis and treatment in Thailand to conduct HIV cure research
por: Muccini, Camilla, et al.
Publicado: (2019)

HIV/AIDS Vaccines: 2018
por: Robinson, Harriet L.
Publicado: (2018)

Toward an HIV preventive vaccine: problems and prospects
por: Gallo, Robert C
Publicado: (2009)

Insights on common vaccinations in HIV-infection: efficacy and safety
por: NICOLINI, L.A., et al.
Publicado: (2015)

Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
por: Clarke, David K., et al.
Publicado: (2006)

HIV Vaccine Mystery and Viral Shell Disorder
por: Goh, Gerard Kian-Meng, et al.
Publicado: (2019)

COVID-19 Vaccine Acceptance: We Need to Start Now
por: Kuppalli, Krutika, et al.
Publicado: (2021)

The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects
por: Liu, Huan, et al.
Publicado: (2018)

Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
por: Rudometova, N.B., et al.
Publicado: (2022)

Catching Chances: The Movement to Be on the Ground and Research Ready before an Outbreak
por: Brett-Major, David, et al.
Publicado: (2018)

Hepatitis C Virus Vaccine: Challenges and Prospects
por: Duncan, Joshua D., et al.
Publicado: (2020)

Vaginal rings for delivery of HIV microbicides
por: Malcolm, R Karl, et al.
Publicado: (2012)

Prophylactic and Therapeutic Vaccination against Hepatitis C Virus (HCV): Developments and Future Perspectives
por: Major, Marian E.
Publicado: (2009)

A review on edible vaccines and their prospects
por: Gunasekaran, B., et al.
Publicado: (2020)

Mumps to COVID-19: Vaccinated persons remain vulnerable when community uptake is low
por: Gaffney, Kristin K., et al.
Publicado: (2022)

Current Status of HIV-1 Vaccines
por: Hargrave, Anna, et al.
Publicado: (2021)

Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study
por: Capitine, Igor P. U., et al.
Publicado: (2021)

Predictors of All-Cause Mortality Among People With Human Immunodeficiency Virus (HIV) in a Prospective Cohort Study in East Africa and Nigeria( )
por: Kibuuka, Hannah, et al.
Publicado: (2021)

Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection
por: French, Martyn A., et al.
Publicado: (2013)

COVID-19 Vaccines for HIV-Infected Patients
por: Plummer, Maria M., et al.
Publicado: (2021)

Prospects for Foamy Viral Vector Anti-HIV Gene Therapy
por: Nalla, Arun K., et al.
Publicado: (2016)

Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study
por: Crowell, Trevor A, et al.
Publicado: (2016)

An HIV/AIDS Prophylactic vaccine is possible
por: Zhong, Qiu, et al.
Publicado: (2007)

DNA/MVA Vaccines for HIV/AIDS
por: Iyer, Smita S., et al.
Publicado: (2014)

DNA Immunization for HIV Vaccine Development
por: Chen, Yuxin, et al.
Publicado: (2014)

Virus-Like-Vaccines against HIV
por: Andersson, Anne-Marie C., et al.
Publicado: (2018)

Advances in HIV-1 Vaccine Development
por: Gao, Yong, et al.
Publicado: (2018)

An Update on the HIV DNA Vaccine Strategy
por: Hokello, Joseph, et al.
Publicado: (2021)

Influenza B: Prospects for the Development of Cross-Protective Vaccines
por: Tsybalova, Liudmila M., et al.
Publicado: (2022)

Natural infection as a blueprint for rational HIV vaccine design
por: van Haaren, Marlies M., et al.
Publicado: (2016)

Prospects for immunotherapy and vaccines against Cryptosporidium
por: Mead, Jan R
Publicado: (2014)

HIV Vaccination: A Roadmap among Advancements and Concerns
por: Trovato, Maria, et al.
Publicado: (2018)

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection
por: McConville, Christopher, et al.
Publicado: (2014)

HIV DNA Vaccine: Stepwise Improvements Make a Difference
por: Felber, Barbara K., et al.
Publicado: (2014)

On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder
por: Uversky, Vladimir N.
Publicado: (2021)

Biting the hand that feeds: current opinion on the interpersonal causes, correlates, and consequences of borderline personality disorder
por: Crowell, Sheila E.
Publicado: (2016)

Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
por: Deviatkin, Andrei A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3fj2gn1nb06qknj694u7as70up